Westlake, OH, United States of America

Paul Saluan

This inventor holds 1 USPTO granted patent. Top assignee: Vivex Biologics Group, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Paul Saluan. Retrieved from https://idiyas.com/inventor/paul-saluan-bqciczy7

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Paul Saluan and a Meniscus Tear Repair Sling Device.

Introduction

Paul Saluan is an inventor associated with Westlake, Ohio, and the company Vivex Biologics Group, Inc. His patent work addresses a surgical approach to repairing a torn meniscus.

Latest Patents

Saluan is associated with 1 patent, titled “Meniscus Tear Repair Sling Device.” The invention uses a collagen membrane with two end portions. One portion passes beneath a meniscus tear, wraps over it, and overlaps the other portion, forming a sling around the injured area. The ends extend outside the knee joint and are affixed to the tibia. When tensioned, they apply lateral strain intended to close the tear.

Career Highlights

The patent describes a device designed to support meniscus repair by securing the torn tissue with a collagen membrane and anchoring its tails to the tibia. Saluan’s listed company affiliation is Vivex Biologics Group, Inc.

Collaborations

Saluan’s listed coworker is Timothy Ganey. The available information identifies their association but does not specify particular joint projects or contributions.

Conclusion

Paul Saluan’s patent centers on a collagen sling device intended to close a meniscus tear through tension applied from outside the knee joint.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…